|
1
|
Lawrence YR, Vikram B, Dignam JJ,
Chakravarti A, Machtay M, Freidlin B, Takebe N, Curran WJ Jr,
Bentzen SM, Okunieff P, et al: NCI-RTOG translational program
strategic guidelines for the early-stage development of
radiosensitizers. J Natl Cancer Inst. 105:11–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsai MH, Cook JA, Chandramouli GV, DeGraff
W, Yan H, Zhao S, Coleman CN, Mitchell JB and Chuang EY: Gene
expression profiling of breast, prostate, and glioma cells
following single versus fractionated doses of radiation. Cancer
Res. 67:3845–3852. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
John-Aryankalayil M, Palayoor ST, Cerna D,
Simone CB II, Falduto MT, Magnuson SR and Coleman CN: Fractionated
radiation therapy can induce a molecular profile for therapeutic
targeting. Radiat Res. 174:446–458. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simone CB II, John-Aryankalayil M,
Palayoor ST, Makinde AY, Cerna D, Falduto MT, Magnuson SR and
Coleman CN: mRNA expression profiles for prostate cancer following
fractionated irradiation are influenced by p53 status. Transl
Oncol. 6:573–585. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Palayoor ST, John-Aryankalayil M, Makinde
AY, Falduto MT, Magnuson SR and Coleman CN: Differential expression
of stress and immune response pathway transcripts and miRNAs in
normal human endothelial cells subjected to fractionated or
single-dose radiation. Mol Cancer Res. 12:1002–1015. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
John-Aryankalayil M, Palayoor ST, Makinde
AY, Cerna D, Simone CB II, Falduto MT, Magnuson SR and Coleman CN:
Fractionated radiation alters oncomir and tumor suppressor miRNAs
in human prostate cancer cells. Radiat Res. 178:105–117. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao L, Lu X and Cao Y: MicroRNA and
signal transduction pathways in tumor radiation response. Cell
Signal. 25:1625–1634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong P, Zhang T, He D and Hsieh JT:
MicroRNA-145 modulates tumor sensitivity to radiation in prostate
cancer. Radiat Res. 184:630–638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weidhaas JB, Babar I, Nallur SM, Trang P,
Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential
agents to alter resistance to cytotoxic anticancer therapy. Cancer
Res. 67:11111–11116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Balça-Silva J, Neves Sousa S, Gonçalves
AC, Abrantes AM, Casalta-Lopes J, Botelho MF, Sarmento-Ribeiro AB
and Silva HC: Effect of miR-34b overexpression on the
radiosensitivity of non-small cell lung cancer cell lines.
Anticancer Res. 32:1603–1609. 2012.PubMed/NCBI
|
|
11
|
Camphausen K, Purow B, Sproull M, Scott T,
Ozawa T, Deen DF and Tofilon PJ: Orthotopic growth of human glioma
cells quantitatively and qualitatively influences radiation-induced
changes in gene expression. Cancer Res. 65:10389–10393. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pawlik A, Delmar P, Bosse S, Sainz L,
Petat C, Pietu G, Thierry D and Tronik-Le Roux D: Changes in
transcriptome after in vivo exposure to ionising radiation reveal a
highly specialised liver response. Int J Radiat Biol. 85:656–671.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buch K, Peters T, Nawroth T, Sänger M,
Schmidberger H and Langguth P: Determination of cell survival after
irradiation via clonogenic assay versus multiple MTT Assay-a
comparative study. Radiat Oncol. 7:12012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Duncan D, Shi Z and Zhang B:
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): Update 2013.
Nucleic Acids Res. 41:(Web Server issue). W77–W83. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C,
Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0:
Service integration into miRNA functional analysis workflows.
Nucleic Acids Res. 41:(Web Server issue). W169–W173. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vlachos IS, Kostoulas N, Vergoulis T,
Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD,
Prionidis K, Dalamagas T and Hatzigeorgiou AG: DIANA miRPath v.2.0:
Investigating the combinatorial effect of microRNAs in pathways.
Nucleic Acids Res. 40:(Web Server issue). W498–W504. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative pcr and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Butkytė S, Čiupas L, Jakubauskienė E,
Vilys L, Mocevicius P, Kanopka A and Vilkaitis G:
Splicing-dependent expression of microRNAs of mirtron origin in
human digestive and excretory system cancer cells. Clin
Epigenetics. 8:332016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rashi-Elkeles S, Elkon R, Shavit S,
Lerenthal Y, Linhart C, Kupershtein A, Amariglio N, Rechavi G,
Shamir R and Shiloh Y: Transcriptional modulation induced by
ionizing radiation: p53 remains a central player. Mol Oncol.
5:336–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fei P and El-Deiry WS: P53 and radiation
responses. Oncogene. 22:5774–5783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mirzayans R, Andrais B, Scott A and Murray
D: New insights into p53 signaling and cancer cell response to DNA
damage: Implications for cancer therapy. J Biomed Biotechnol.
2012:1703252012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Willis N and Rhind N: Regulation of DNA
replication by the S-phase DNA damage checkpoint. Cell Division.
4:132009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cazzalini O, Scovassi AI, Savio M, Stivala
LA and Prosperi E: Multiple roles of the cell cycle inhibitor
p21CDKN1A in the DNA damage response. Mutat Res. 704:12–20. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shepperd LA, Meadows JC, Sochaj AM,
Lancaster TC, Zou J, Buttrick GJ, Rappsilber J, Hardwick KG and
Millar JB: Phosphodependent recruitment of Bub1 and Bub3 to
Spc7/KNL1 by Mph1 kinase maintains the spindle checkpoint. Curr
Biol. 22:891–899. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Formenti SC and Demaria S: Combining
radiotherapy and cancer immunotherapy: A paradigm shift. J Natl
Cancer Inst. 105:256–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Derer A, Deloch L, Rubner Y, Fietkau R,
Frey B and Gaipl US: Radio-immunotherapy-induced immunogenic cancer
cells as basis for induction of systemic anti-tumor immune
responses-pre-clinical evidence and ongoing clinical applications.
Front Immunol. 6:5052015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wattenberg MM, Fahim A, Ahmed MM and Hodge
JW: Unlocking the combination: Potentiation of radiation-induced
antitumor responses with immunotherapy. Radiat Res. 182:126–138.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
O'Shea JJ, Schwartz DM, Villarino AV,
Gadina M, McInnes IB and Laurence A: The JAK-STAT pathway: Impact
on human disease and therapeutic intervention. Annu Rev Med.
66:311–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Au-Yeung N, Mandhana R and Horvath CM:
Transcriptional regulation by STAT1 and STAT2 in the interferon
JAK-STAT pathway. JAKSTAT. 2:e239312013.PubMed/NCBI
|
|
32
|
Cheon H, Holvey-Bates EG, Schoggins JW,
Forster S, Hertzog P, Imanaka N, Rice CM, Jackson MW, Junk DJ and
Stark GR: IFNβ-dependent increases in STAT1, STAT2, and IRF9
mediate resistance to viruses and DNA damage. EMBO J. 32:2751–2763.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stegeman H, Kaanders JH, Verheijen MM,
Peeters WJ, Wheeler DL, Iida M, Grénman R, van der Kogel AJ, Span
PN and Bussink J: Combining radiotherapy with MEK1/2, STAT5 or
STAT6 inhibition reduces survival of head and neck cancer lines.
Mol Cancer. 12:1332013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kalbasi A, June CH, Haas N and Vapiwala N:
Radiation and immunotherapy: A synergistic combination. J Clin
Invest. 123:2756–2763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Frey B, Rubner Y, Kulzer L, Werthmöller N,
Weiss EM, Fietkau R and Gaipl US: Antitumor immune responses
induced by ionizing irradiation and further immune stimulation.
Cancer Immunol Immunother. 63:29–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dewan MZ, Galloway AE, Kawashima N,
Dewyngaert JK, Babb JS, Formenti SC and Demaria S: Fractionated but
not single-dose radiotherapy induces an immune-mediated abscopal
effect when combined with anti-CTLA-4 antibody. Clin Cancer Res.
15:5379–5388. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schaue D, Ratikan JA, Iwamoto KS and
McBride WH: Maximizing tumor immunity with fractionated radiation.
Int J Radiat Oncol Biol Phys. 83:1306–1310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kulzer L, Rubner Y, Deloch L, Allgäuer A,
Frey B, Fietkau R, Dörrie J, Schaft N and Gaipl US: Norm- and
hypo-fractionated radiotherapy is capable of activating human
dendritic cells. J Immunotoxicol. 11:328–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Metheetrairut C and Slack FJ: MicroRNAs in
the ionizing radiation response and in radiotherapy. Curr Opin
Genet Dev. 23:12–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hermeking H: p53 Enters the MicroRNA
World. Cancer Cell. 12:414–418. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Girardi C, De Pittà C, Casara S, Sales G,
Lanfranchi G, Celotti L and Mognato M: Analysis of miRNA and mRNA
expression profiles highlights alterations in ionizing radiation
response of human lymphocytes under modeled microgravity. PLoS One.
7:e312932012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Josson S, Sung SY, Lao K, Chung LW and
Johnstone PA: Radiation modulation of microRNA in prostate cancer
cell lines. Prostate. 68:1599–1606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Leung CM, Chen TW, Li SC, Ho MR, Hu LY,
Liu WS, Wu TT, Hsu PC, Chang HT and Tsai KW: MicroRNA expression
profiles in human breast cancer cells after multifraction and
single-dose radiation treatment. Oncol Rep. 31:2147–2156.
2014.PubMed/NCBI
|
|
44
|
Jayaswal V, Lutherborrow M, Ma DD and Yang
Hwa Y: Identification of microRNAs with regulatory potential using
a matched microRNA-mRNA time-course data. Nucleic Acids Res.
37:e602009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hermeking H: MicroRNAs in the p53 network:
Micromanagement of tumour suppression. Nat Rev Cancer. 12:613–626.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cannell IG, Kong YW, Johnston SJ, Chen ML,
Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, et
al: p38 MAPK/MK2-mediated induction of miR-34c following DNA damage
prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA.
107:5375–5380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Achari C, Winslow S, Ceder Y and Larsson
C: Expression of miR-34c induces G2/M cell cycle arrest in breast
cancer cells. BMC Cancer. 14:5382014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li F, Chen H, Huang Y, Zhang Q, Xue J, Liu
Z and Zheng F: miR-34c plays a role of tumor suppressor in HEC1-B
cells by targeting E2F3 protein. Oncol Rep. 33:3069–3074.
2015.PubMed/NCBI
|
|
49
|
Luo J, Chen J and He L: mir-129-5p
attenuates irradiation-induced autophagy and decreases
radioresistance of breast cancer cells by targeting HMGB1. Med Sci
Monit. 21:4122–4129. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li XH, Ha CT, Fu D and Xiao M:
Micro-RNA30c negatively regulates REDD1 expression in human
hematopoietic and osteoblast cells after gamma-irradiation. PLoS
One. 7:e487002012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gregersen LH, Jacobsen AB, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-145 targets in colon cancer cells.
PLoS One. 5:e88362010. View Article : Google Scholar : PubMed/NCBI
|
